8HYL image
Entry Detail
PDB ID:
8HYL
Keywords:
Title:
Crystal structure of DO1 Fv-clasp fragment
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-01-06
Release Date:
2024-02-14
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.29
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:VH-SARAH
Chain IDs:A, C
Chain Length:170
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:VL-SARAH
Chain IDs:B, D
Chain Length:165
Number of Molecules:2
Biological Source:Mus musculus
Primary Citation
Molecular and structural basis of anti-DNA antibody specificity for pyrrolated proteins.
Commun Biol 7 149 149 (2024)
PMID: 38310133 DOI: 10.1038/s42003-024-05851-0

Abstact

Anti-DNA antibodies (Abs), serological hallmarks of systemic lupus erythematosus (SLE) and markers for diagnosis and disease activity, show a specificity for non-nucleic acid molecules, such as N-pyrrolated proteins (pyrP) containing Nε-pyrrole-L-lysine (pyrK) residues. However, the detailed mechanism for the binding of anti-DNA Abs to pyrP remains unknown. In the present study, to gain structural insights into the dual-specificity of anti-DNA Abs, we used phage display to obtain DNA-binding, single-chain variable fragments (scFvs) from SLE-prone mice and found that they also cross-reacted with pyrP. It was revealed that a variable heavy chain (VH) domain is sufficient for the recognition of DNA/pyrP. Identification of an antigenic sequence containing pyrK in pyrP suggested that the presence of both pyrK and multiple acidic amino acid residues plays important roles in the electrostatic interactions with the Abs. X-ray crystallography and computer-predicted simulations of the pyrK-containing peptide-scFv complexes identified key residues of Abs involved in the interaction with the antigens. These data provide a mechanistic insight into the molecular basis of the dual-specificity of the anti-DNA Abs and provide a basis for therapeutic intervention against SLE.

Legend

Protein

Chemical

Disease

Primary Citation of related structures